Home › Products › Oncology › Dsatinib ML 50mg Tablet
Dsatinib ML 50mg Tablet
Salt Composition: DASATINIB
- Manufacturer: METTA LIFE SCIENCES PVT LTD
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 50MG
- Prescription Required
- Storage: Store protected from light at a temperature not exceeding 30°C.
₹4529.00₹12937.50
Inclusive of all taxes
Product Introduction
Dasatinib ML 50mg Tablet contains the active ingredient Dasatinib, a targeted therapy medication. This prescription medicine is indicated for adults and children above one year of age with Chronic Myeloid Leukaemia.
Dasatinib 50mg is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia in the chronic phase and Ph+ acute lymphoblastic leukaemia in patients resistant to other therapies. Chronic Myeloid Leukaemia is a type of blood cancer characterised by excess production of white blood cells due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukaemia is the most common form of blood cancer affecting children, where lymphocytes of white blood cells multiply excessively and persist longer than normal.
Common side effects associated with this medication include diarrhoea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and elevated or reduced blood pressure. Fluid retention may also occur as a side effect. Inform your doctor if these side effects cause concern or persist.
Advise your healthcare professional if you are allergic to Dasatinib or its ingredients. Before starting treatment, inform your physician if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine may cause severe reduction in the number of platelets, white blood cells, or red blood cells. Ensure your physician monitors your blood levels at regular intervals.
Tell your healthcare professional about all medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. Generic alternatives are available; consult your doctor before switching medications.
This medicine is not recommended for children below one year of age.
Uses
Dsatinib ML 50mg uses are: Children and adults with chronic myeloid leukaemia. Adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) with resistance to prior therapy.
How it works
Dsatinib ML 50mg Tablet works by preventing the abnormal protein from signalling the growth of cancer cells. This aids in preventing or reducing the spread of cancer cells.
How to Use
Take the tablet with or without food at the same time each day.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Dasatinib ML 50mg side effects are Serious side effects are: Unusual bleeding or bruising Rapid heart rate Changes in consciousness or speech Breathlessness and swelling all over the body Fever or signs of infection Fluid retention Heart problems Myelosuppression Severe allergic reaction Common side effects are: Diarrhea Headache Cough Rash Nausea, tiredness, vomiting Muscle pain, weakness Low appetite High or low BP
References
- Bristol-Myers Squibb Pharma, Electronic Medicines Compendium (EMC), [Revised on Mar 2022] [Accessed on 1st Dec 2022], https://www.medicines.org.uk/emc/files/pil.7745.pdf
- Bristol-Myers Squibb Company, [Revised on Jun 2021] [Accessed on 1st Dec 2022], https://packageinserts.bms.com/ppi/ppi_sprycel.pdf
- H.G. Watson, J.I.O. Craig, L.M. Manson, Blood disease, Davidsonâs Principles and Practice of Medicine, 22nd Edition, 2014, 989-1056.
- Edward Chu, Cancer Chemotherapy, Langeâs Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
Safety Advice
Pregnancy: unsafe Dsatinib ML 50mg Tablet is not recommended to use during pregnancy unless clearly necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.
Lungs: Consult Your Doctor It is unknown whether Dsatinib ML 50mg Tablet is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
Breastfeeding: unsafe It is not recommended to breastfeed while taking Dsatinib ML 50mg Tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.